Abstract
Insulin therapy is known to escalate the risk of heart failure (HF) exacerbation and increase the risk of HF hospitalisation. However, there is a lack of outcome trials evaluating the left ventricular ejection fraction (LVEF) outcomes of insulin in Malaysia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
